13 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
89bio - Clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat people with liver and cardiometabolic diseases.
Acelrx Pharmaceuticals - Talphera is developing Niyad™, nafamostat, for renal replacement therapy in dialysis patients who cannot tolerate heparin or have an increased risk of bleeding
Akero Therapeutics - Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).
Crinetics Pharmaceuticals - Crinetics is here for endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.
Cymabay Therapeutics - Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Enanta Pharmaceuticals - At Enanta, we are committed to creating important, novel medicines by pursuing bold ideas, employing rigorous research, and striving for scientific excellence in everything we do. We are fortunate to have some of the best and brightest minds across pharma and biotech working at Enanta. We are passionate about science and dedicated to discovering and developing highly differentiated therapeutics through innovative chemistry to treat diseases in areas of high unmet need.
Intercept Pharmaceuticals - Using key discoveries in the field of liver health, we’re advancing treatments for rare and serious liver diseases. Our portfolio is based on novel scientific targets with the potential for therapeutic application across multiple liver diseases. Since 2002, we’ve pioneered a novel scientific platform to answer critical needs in the liver health community and deliver on our mission to build a healthier tomorrow for people with rare and serious liver diseases.
Madrigal Pharmaceuticals - The Madrigal story began in the early 2000s when founder Rebecca Taub, M.D., began applying her unique understanding of liver biology to explore therapies for MASH and metabolic disease.
Metacrine - Metacrine is a metabolic diseases company headquartered in San Diego, CA, founded in 2014.
NGM Biopharmaceuticals - Our broad, diverse pipeline of novel, first-in-class medicines spans multiple therapeutic areas and diseases. Every program focuses on a large market indication with high unmet needs and a common goal: delivering outsized impact for patients.
Scholar Rock - Our approach aims to selectively target protein growth factors before they are activated—like shutting off the water supply before a faucet starts leaking. Traditional approaches instead focus on “mopping up” the water after it has already spilled. We are applying this approach to diseases where protein growth factors play a central role.
Viking Therapeutics - Marianne Mancini serves as our Chief Operating Officer. Ms. Mancini has over 30 years of experience in the pharmaceutical and biotechnology industry focusing on the management and oversight of clinical trials from early-stage to late-stage drug development and most recently served as the company’s senior vice president of clinical operations.
Zafgen - Biotrim Maximum einer der wichtigsten Faktoren beim Abnehmen ist die richtige Ernährung. Wenn Sie zu viel ungesunde Lebensmittel zu sich nehmen, die Portionen nicht kontrollieren oder sich nicht ausgewogen ernähren, können Sie ein Faktor sein, der den Gewichtsverlustprozess behindert. Die Erstellung eines gesunden und ausgewogenen Ernährungsplans und die Überprüfung der Essgewohnheiten können Ihnen beim Abnehmen Weiterlesen NightBeast je gesünder ein Mensch ist, desto mehr Lachgas produziert er.